| Animal products (available studies) | Animal | Commodity | T (°C) | Stability period | Compounds covered | Comment/Source | |
|---|---|---|---|---|---|---|---|
| Value | Unit | ||||||
| Bovine | Muscle | –20 | 127 | Days | Flutolanil, M‐2, M‐4, M‐07a | EFSA (2019b) | |
| Bovine | Fat | –20 | 88 | Days | Flutolanila | EFSA (2019b) | |
| Bovine | Fat | –20 | < 88b | Days | M‐2, M‐4, M‐07a | EFSA (2019b) | |
| Chicken | Liver | –20 | 122 | Days | Flutolanil, M‐2, M‐4, M‐07a | EFSA (2019b) | |
| Bovine | Milk | –20 | 115 | Days | Flutolanil, M‐2, M‐4, M‐07a | EFSA (2019b) | |
| Chicken | Eggs | –20 | 125 | Days | Flutolanil, M‐2, M‐4, M‐07a | EFSA (2019b) | |
a
Samples were separately fortified with flutolanil or with M‐2 or with M‐4 or with M‐07 to assess the storage stability for each compound independently. However, the method used in the study was a common moiety method which hydrolysed flutolanil and metabolites to 2‐trifluoromethylbenzoic acid.
b
A significant decline was observed for M‐2, M‐4 and M‐07 in fat matrix already at the first time point of 88 days.